Pesquisar | AC Mingle

NutrWellnessHub adicionou um novo artigo Art
2026-08-29 09:17:58 -

LumiMeds GLP1: Understanding Tirzepatide and GLP-1 Care
Introduction LumiMeds GLP1 is an web-based weight loss service that is medically supervised through the LumiMeds platform. The programme may include compounded semaglutide, compounded tirzepatide, or another medication chosen by a licensed healthcare provider, per the patient’s medical history and eligibility. These treatments are prescription medications, not...

0 Comentários 0 Compartilhamentos 248 Visualizações 0 Anterior

Faça Login para curtir, compartilhar e comentar!
atharv2711 adicionou um novo artigo Outro
2026-09-21 10:16:30 -

Tirzepatide API Market Size to Reach USD 8.80 Billion by 2034 at 17.9% CAGR | Market Share, Growth, Forecast & Outlook
According to a report by Intel Market Research, the global Tirzepatide API Market was valued at USD 1.86 billion in 2025, estimated at USD 2.35 billion in 2026, and projected to reach USD 8.80 billion by 2034, representing a 17.9% CAGR during 2026–2034. The market covers pharmaceutical-grade tirzepatide active pharmaceutical ingredient used in regulated finished-dose manufacturing, while...

0 Comentários 0 Compartilhamentos 237 Visualizações 0 Anterior

Faça Login para curtir, compartilhar e comentar!
Rutujad adicionou um novo artigo Outro
2026-09-22 09:19:54 -

GLP-1 Agonists Weight Loss Drugs Market Demand for Convenient Treatment Options
The weight management industry is moving through a major shift as pharmaceutical treatments become an increasingly visible part of obesity care. GLP-1-based medicines have moved from being primarily associated with metabolic disease management to becoming a major category within weight loss treatment, supported by rising obesity prevalence, clinical efficacy, greater awareness, and expanding...

0 Comentários 0 Compartilhamentos 465 Visualizações 0 Anterior

Faça Login para curtir, compartilhar e comentar!
mahir007 adicionou um novo artigo Outro
2026-11-04 11:28:24 -

GLP-1 Receptor Agonists Obesity Drugs Market Size, Share & Forecast 2033
According to the latest report published by Data Bridge Market Research, the GLP-1 Receptor Agonists Obesity Drugs Market CAGR Value With the effectual use of technology, innovative applications and expertise, GLP-1 Receptor Agonists Obesity Drugs Market research report has been generated which successfully manages bulky and complex market data tables. This report displays...

0 Comentários 0 Compartilhamentos 94 Visualizações 0 Anterior

Faça Login para curtir, compartilhar e comentar!